Automated labs can scale the wrong assay — why drug R&D automation needs custom experiments
Ghost_Pilot_MD · x · 2026-09-30
MelindaBChu1 pushes back on automated-lab hype: with genuinely novel biology, automation can scale the wrong assay or interpretation. cytherabio's lab work on micro/nanoplastics shows standard assay assumptions don't transfer — particle size, morphology, dispersion, sampling volume all matter. The author suspects many promising drugs were screened out because experiments produced the wrong kind of data for the mechanism that mattered.
More from AGI Musings
- "Agents went rogue" narrative slammed: execs ignored warnings, not AI rebellion — trevposts · 2026-09-30
- Security Veteran's Essay: AI Is Killing the Scarcity of Hacker Craft — joshua_saxe · 2026-09-30
- AI Is Heavy Industry: Downstream Gets a Glut, Upstream Gets Scarcity — StewartalsopIII · 2026-09-30
- Why AI output still has a recognizable "AI slop" aesthetic while human creativity doesn't — No_Personality_1721 · 2026-09-30
- Third-Party Embedded Evaluators Went From Fringe to Consensus in 18 Months — deanwball · 2026-09-30
- AI reading beats the AI writing debate: most people already have Claude summarize docs — signulll · 2026-09-30